Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516729 | SCV000613364 | uncertain significance | not specified | 2017-04-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001707717 | SCV000726580 | likely benign | not provided | 2020-12-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001034398 | SCV001197740 | likely benign | Epilepsy, childhood absence, susceptibility to, 1; Epilepsy, childhood absence, susceptibility to, 5 | 2024-07-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002527474 | SCV003731621 | likely benign | Inborn genetic diseases | 2021-07-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV003129879 | SCV003816276 | uncertain significance | Developmental and epileptic encephalopathy, 43 | 2022-08-24 | criteria provided, single submitter | clinical testing |